article thumbnail

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

Additionally, by buying smart toothbrushes from companies like Procter & Gamble and Philips Oral Healthcare you agree to their privacy policies that enable them to share your data with third parties. Its importance was also highlighted during the COVID-19 crisis to bypass supply chains to meet hospitals’ demands.

Patients 126
article thumbnail

The Wholesaling Prohibition (Potentially) Demystified? FDA’s Take on Supply Chains for Section 503B Outsourcing Facilities

FDA Law Blog

Under section 503B, drugs compounded by an FDA-registered outsourcing facility under the supervision of a licensed pharmacist can qualify for exemptions from FDA approval, labeling with adequate directions for use, and certain drug supply chain security requirements, subject to specific conditions. See 21 U.S.C. Section II at 2.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Rising Tide of Medical Waste: One Model for Improvement

My Green Doctor

Medical waste is a broad term used to describe any waste products generated at healthcare facilities and includes everything ranging from the disposal of small needles to the energy consumption of radiologic scans. The product manufacturers and vendors will need to be active partners as well. The use of medications in U.S.

Medical 52
article thumbnail

FDA Takes Another Small Step to Increase Naloxone Access

FDA Law Blog

Most states have some form of naloxone standing order that allows a healthcare provider to write a prescription that covers a large group of people rather than just an individual patient. Because naloxone is a prescription drug, its distribution is subject to the requirements of the Drug Supply Chain Security Act (DSCSA).

article thumbnail

Biden “Promoting Competition” Executive Order Falls In Behind Drug Importation

FDA Law Blog

Two states have submitted importation plans to FDA for approval, but the rule and the certification were promptly challenged in federal court by the Pharmaceutical Research and Manufacturers of America (PhRMA) and other interest groups. Among the Order’s mandates for DHHS are several relating to prescription drugs.